Semaglutide Injection
Formulation (FDF) · Injection · 0.68mg/ml, 1.5ml ; 1.34mg/ml, 1.5ml; 1.34mg/ml, 3ml ; 2.27mg/ml, 3ml; 3.2mg/ml, 3ml
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Semaglutide Injection
- Dosage Form
- Injection
- Strength
- 0.68mg/ml, 1.5ml ; 1.34mg/ml, 1.5ml; 1.34mg/ml, 3ml ; 2.27mg/ml, 3ml; 3.2mg/ml, 3ml
- Therapy Area
- Metabolic & Endocrinology
- Indication
- Type 2 diabetes mellitus; Obesity; Overweight
- Current Status
- Official FDF licensing catalog (UB599)
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3002.15
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price